0001713695-20-000004.txt : 20200702 0001713695-20-000004.hdr.sgml : 20200702 20200702142849 ACCESSION NUMBER: 0001713695-20-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 EFFECTIVENESS DATE: 20200702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imbria Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745672 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830858012 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370161 FILM NUMBER: 201008380 BUSINESS ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: SUITE #1702 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 858-413-7899 MAIL ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: SUITE #1702 CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001745672 Imbria Pharmaceuticals, Inc. 265 FRANKLIN STREET SUITE #1702 BOSTON MA MASSACHUSETTS 02110 858-413-7899 DELAWARE None None Corporation true 2018 David-Alexandre C. Gros c/o Imbria Pharmaceuticals, Inc. 265 Franklin Street, Suite #1702 Boston MA MASSACHUSETTS 02110 Executive Officer Andrew Levin c/o Imbria Pharmaceuticals, Inc. 265 Franklin Street, Suite #1702 Boston MA MASSACHUSETTS 02110 Director James Januzzi c/o Imbria Pharmaceuticals, Inc. 265 Franklin Street, Suite #1702 Boston MA MASSACHUSETTS 02110 Director Pharmaceuticals Decline to Disclose 06b false 2020-06-22 false true true false 0 80734932 40734932 40000000 false 4 0 0 0 false Imbria Pharmaceuticals, Inc. /s/ David-Alexandre C. Gros David-Alexandre C. Gros Chief Executive Officer 2020-07-02